Skip to content

Cash ratio at other companies

Inspire Medical Systems logo
Inspire Medical SystemsINSP
1.1×+0.3×

Other financials

Income statement

See full
Revenue$39.0K-15.2%
Gross profit-$274.0K-52.2%
Operating income-$6.0M-16.7%
Net income-$4.4M+12.9%
EPS (diluted)-$0.08+72.4%

Balance sheet

See full
Cash & equivalents$25.3M+376%
Total debt$919.0K-2.8%
Total equity$10.2M+142%
Total assets$29.8M+187%

Cash flow

See full
Operating cash flow-$6.1M-62.7%
CapEx$172.0K
Free cash flow-$5.9M-28.5%

Valuation

See full
Market cap$61M+83.5%
P/S260.7×+111×

Profitability

See full
Gross margin-310.7%+31.6pp
Operating margin-9,881.2%+805pp
Net margin-9,875.6%+771pp
FCF margin-7,626.6%-652pp

Returns & leverage

See full
Return on equity328.7%
Debt / equity0.1×
Current ratio2.3×+1.2×

Where this comes from

Calculated from Envoy Medical’s reported figures.

Based on the most recent quarter.

The official record: Envoy Medical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Envoy Medical's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Envoy Medical's cash ratio?
Envoy Medical (COCH) reported cash ratio of 2.1× in Q1 2026.
How has Envoy Medical's cash ratio changed year-over-year?
Envoy Medical's cash ratio increased by 196.3% year-over-year, from 0.7× to 2.1×.
What is the long-term trend for Envoy Medical's cash ratio?
Over 5 years (2020 to 2025), Envoy Medical's cash ratio has grown at a 4.4% compound annual growth rate (CAGR), from 0.3× to 0.3×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.